Two Years of Menaquinone-7 Supplementation Attenuates Coronary Artery Calcification Progression: Evidence from Randomized Clinical Trials
Menaquinone-7 (MK-7) supplementation over two years significantly slows progression of coronary artery calcification (CAC) in symptomatic coronary artery disease patients, with favorable safety and potential implications for plaque stabilization.